Rose Raizman receives EWMA e-poster prize (May 16, 2017)


An e-poster featuring MolecuLight by Rose Raizman, RN-EC MSc, presented at the recent EWMA meeting in Amsterdam, has been selected to receive one of the four e-poster prizes awarded from this year’s meeting. Her study, entitled “Real-time fluorescence imaging of bacteria guides treatment selection and timing of dressing changes in patients undergoing negative pressure wound […]

Read More

How will fluorescence imaging impact wound care? (April 24, 2017)

Effective wound management is a challenge for healthcare.  In Canada, wounds cost $3.9 billion annually (approximately 3% of total healthcare expenditures).  Individuals with chronic wounds experience harmful consequences including intractable pain, infectious complications, hospitalization, reduced quality of life, depression, and increased risk of death.  With the continued rise in the incidence of diabetes and obesity, […]

Read More

Will the ‘urgent need’ for new drugs be sufficient in the fight against bacteria? (February 27 2017)

Three of the most fearsome bacteria in the world are Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae.  This is because these bacteria have developed resistance to key antibiotic drugs since the more an antibiotic is used, the less effective it becomes over time. The reality of the antibiotic market works against the traditional pharmaceutical marketing strategy.  Rather than being used […]

Read More